Become an AAHPM Member to view PC-FACS
This systematic review is geared toward evidence to use guided imagery for symptomatic cancer patients. The authors’ conclusion is that guided imagery therapy has shown promising results regarding symptom management in palliative care patients with life-limiting illnesses at different stages. Patients who received guided imagery experienced relief from anxiety, depression, pain, sleep disturbances, and fatigue.
This is a first systematic review of use of dexmedetomidine for delirium and pain in palliative care. This agent is a promising option for refractory pain and delirium and may contribute to a reduction in opioid administration to control pain.
The authors describe a case series of palliative care patients with major depression and suicidal ideation who were treated with intranasal esketamine with substantial reduction in depression severity and no further suicidal ideation. These improvements were maintained for up to a year. No serious adverse events occurred. The authors are adding to scarce literature of collective evidence of use of intranasal ketamine for depression in palliative care.